Skip to content
Local Portal News

Providing Stem Cells During Pregnancy to Babies with Spina Bifida Boosts Quality of Life, Research Shows

An innovative medical trial has discovered that providing pluripotent cells to unborn babies diagnosed with spina bifida during corrective surgery could constitute a "significant breakthrough" in treating birth defects.

Trial Details and Safety

The research conducted in the United States examined six developing infants with the 'open' form of spina bifida. Doctors administered regenerative cells sourced from the maternal placenta directly onto the baby's spinal cord as part of the surgical correction.

Significantly, the regenerative treatment proved to be secure. The study team reported that the therapy did not induce neoplasms, hinder surgical recovery, or impede the resolution of co-occurring hindbrain herniation.

Promising Outcomes

Magnetic resonance imaging performed on the newborns showed a complete reversal of Chiari malformation in all six infants. This neurological improvement is closely linked to enhanced physical outcomes.

"In the event it allows additional babies to achieve ambulation who otherwise would not, it may emerge as the new treatment paradigm," noted the study director. "The results are profoundly encouraging and pave the way for numerous possible new treatments."

Broader Impact and Encouragement

Independent medical specialists proposed that additional validation of these observed advantages could herald a "different age" in fetal surgery. The potential to improve nerve function impairment seen in utero is considered a paradigm-shifting aim.

Especially significant would be improvements in urogenital and gastrointestinal outcomes, which are common challenges for those diagnosed with this defect.

The Path Forward

Despite this being a first-in-human effort focused on a handful of cases, its confirmed tolerability and hopeful trends create a solid basis for expanded clinical research. The integration of stem cell therapy with proven prenatal surgical methods presents significant potential for changing life trajectories for future generations with myelomeningocele.

About the author

Joseph Glenn

A seasoned journalist with a passion for local storytelling and community journalism.

Local Portal News

Type to search articles.